Advancement in CAR T Cell Therapy for Patients with Multiple Myeloma Helps Predict Treatment Response and Resistance

Researchers from the University of Leipzig Medical Center identify multiple biomarkers associated with the success of CAR T cell therapy in relapsed multiple myeloma.

Related Keywords

,University Of Leipzig Medical Center ,Department For Hematology ,Nature Cancer ,Leipzig Medical Center ,Expressing Monocytes ,Senior Physician ,Cell Therapy ,Nat Cancer ,